Dengue Branch, Division of Vector-Borne Diseases, Centers For Disease Control and Prevention, San Juan, Puerto Rico.
PLoS Negl Trop Dis. 2011 Dec;5(12):e1400. doi: 10.1371/journal.pntd.0001400. Epub 2011 Dec 6.
Dengue often presents with non-specific clinical signs, and given the current paucity of accurate, rapid diagnostic laboratory tests, identifying easily obtainable bedside markers of dengue remains a priority. Previous studies in febrile Asian children have suggested that the combination of a positive tourniquet test (TT) and leucopenia can distinguish dengue from other febrile illnesses, but little data exists on the usefulness of these tests in adults or in the Americas. We evaluated the diagnostic accuracy of the TT and leucopenia (white blood cell count <5000/mm(3)) in identifying dengue as part of an acute febrile illness (AFI) surveillance study conducted in the Emergency Department of Saint Luke's Hospital in Ponce, Puerto Rico. From September to December 2009, 284 patients presenting to the ED with fever for 2-7 days and no identified source were enrolled. Participants were tested for influenza, dengue, leptospirosis and enteroviruses. Thirty-three (12%) patients were confirmed as having dengue; 2 had dengue co-infection with influenza and leptospirosis, respectively. An infectious etiology was determined for 141 others (136 influenza, 3 enterovirus, 2 urinary tract infections), and 110 patients had no infectious etiology identified. Fifty-two percent of laboratory-positive dengue cases had a positive TT versus 18% of patients without dengue (P<0.001), 87% of dengue cases compared to 28% of non-dengue cases had leucopenia (P<0.001). The presence of either a positive TT or leucopenia correctly identified 94% of dengue patients. The specificity and positive predictive values of these tests was significantly higher in the subset of patients without pandemic influenza A H1N1, suggesting improved discriminatory performance of these tests in the absence of concurrent dengue and influenza outbreaks. However, even during simultaneous AFI outbreaks, the absence of leucopenia combined with a negative tourniquet test may be useful to rule out dengue.
登革热常表现为非特异性临床体征,鉴于目前缺乏准确、快速的诊断性实验室检测手段,确定易于获得的登革热床边标志物仍然是当务之急。先前在发热亚洲儿童中的研究表明,阳性束臂试验(TT)和白细胞减少症的组合可将登革热与其他发热性疾病区分开来,但有关这些检测在成人或美洲中的有用性的数据很少。我们评估了 TT 和白细胞减少症(白细胞计数<5000/mm(3))在识别登革热作为波多黎各蓬塞圣卢克医院急诊科进行的急性发热性疾病(AFI)监测研究的一部分的诊断准确性。从 2009 年 9 月至 12 月,共有 284 名发热 2-7 天且无明确病因的患者入组该研究。参与者接受了流感、登革热、钩端螺旋体病和肠病毒检测。33 名(12%)患者被确诊为登革热;2 名患者分别与流感和钩端螺旋体病合并感染登革热。另外 141 名患者确定了感染病因(136 例流感、3 例肠病毒、2 例尿路感染),110 名患者未确定感染病因。52%的实验室阳性登革热病例 TT 阳性,而无登革热的患者为 18%(P<0.001),87%的登革热病例白细胞减少症阳性,而非登革热病例为 28%(P<0.001)。任一 TT 阳性或白细胞减少症阳性可正确识别 94%的登革热患者。在没有大流行性甲型 H1N1 流感的患者亚组中,这些检测的特异性和阳性预测值显著更高,表明在没有同时发生登革热和流感暴发的情况下,这些检测的区分性能有所提高。但是,即使在同时发生 AFI 暴发期间,结合阴性束臂试验无白细胞减少症也可能有助于排除登革热。